Member Info for Chelsea11

I suspect it’s also the case that some of those selling aren’t just Traders, they are Investors who don’t see any short-medium term inflection points ie. they expect the SP to just bumble along sub 225p for the rest of the year and want to place their bets elsewhere.

Https://www.proactiveinvestors.co.uk/companies/news/1038312/ramsdens-sees-record-profits-festive-trading-fails-to-impress-1038312.html

No nasty surprises re anticipated PBT. Overall positive I thought but caution threaded through some of the forward looking statements and wonder what the market will make of that.

Clearly I didn’t describe it as chaff, nor did I make any attempt, or suggestion, that it shouldn’t be read. Crystal clear.

For me though, the content of the Interims are far more important in connection with my investment here. Just a couple of weeks away, assuming on schedule.

Jackdaw - the critical point I’m making, is not at all that the Interims will be the latest news, when issued, more that they will be official news from a known source ie. the Company. Don’t know about you but I’ll place more of my investment decision around that.

Not against reading other material, if clearly relevant to Scancell, context provided and not just chaff lifted from the web (not suggesting this is the latter).

Sorry Ray. That was with reference to the link this morning, not your post!

What is contained within the Interims in just a couple of weeks time, will overtake this ie. horses mouth.

Ruck.

“Everyone is entitled to an opinion”

Absolutely right. By saying that then, you accept that entitlement applies to me also.

I wouldn’t say it’s unreasonable, to suggest someone moves on, when they state they believe they’re invested in a “jam tomorrow” company.

Ah so unlike your original post, you now accept there were posters who don’t believe it was a fiasco.

Agreed.

Can understand the disappointment that the SP is where it is. After all, we’re all here to make a profit on the Share.

However, I don’t see any part of last year as a fiasco and am pretty sure many invested here would agree. As a for instance, for anyone bemoaning the “low Genmab payment”, there are others who see that as a significant step forward for the Company.

Perhaps you should “go check the Forum” to see those alternative views.

“Last years fiasco”

What exactly was that then?

Of course at the other end of the scale, some folks are still holding out for 5p :-)

From the 2023 Conference notes:

“The Conference is also the birthplace of a lot of deals, with companies announcing major transactions in the run-up.”

Maybe Monday morning then! Lol.

Annual Results 15th Jan then and will reveal if PBT is above the £10M anticipated by the Board. Something closer to £10.5M would perhaps be a catalyst for the SP, particularly if accompanied by a bullish outlook statement.

Frankly, these guys at LGB have been waffling on about Scancell for many years. They probably got a Grad to phone up a large list of companies for updates and they had little idea of what the Scancell rep (whoever that actually was) was telling them and scribbled out of context bobbins.

Fake news imo. Company RNS are what matters.

I thought TF was the Schoolmaster round here.

I would hazard a guess that historically, there have been approaches made to Scancell, that have been met with a Pfft response.

If you build it, they will come.

Hi TF - I truly hope JB1’s hunch, is proven to be correct.

Happy New Year everyone.

Sorry TF but that’s not right. There is suggestion of funding and as I rightly say, there is no evidence of that. Scancell are not present in the list of companies who have received funding. Ask yourself why not.